Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nicolin

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Anti-Cancer Drugs|February 1, 1996
Terminally L-modified oligonucleotides: pairing, stability and biological propertiesL Tondelli, A Garbesi, S Morelli, et al.
Anti-Cancer Drug Design|January 1, 1996
Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell lineS Morelli, A Alama, A Quattrone, et al.
British Journal of Cancer|August 1, 1988
DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivityO Marelli, P Franco, G Canti, et al.
Anti-Cancer Drugs|April 1, 1993
Oligonucleotide degradation contributes to resistance to antisense compoundsA Ryte, S Morelli, M Mazzei, et al.
Pharmacological Research|September 1, 1990
Diethylstilbestrol (DES) and recombinant human growth hormone (rhGH) as modulators of breast cancer proliferative activityA Alama, F Barbieri, G Gardin, et al.
Neoplasma|January 1, 1987
Photodynamic therapy in vitro and in vivo with hematoporphyrin derivative and laser lightG Canti, L Ricci, A Ferrario, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1997
The antisense bcl-2-IgH transcript is an optimal target for synthetic oligonucleotidesS Morelli, D Delia, S Capaccioli, et al.
Biochimica Et Biophysica Acta|June 28, 1989
Assimilation of LDL by experimental tumours in miceP Lombardi, G Norata, F M Maggi, et al.
Anticancer Research|November 1, 1988
Plasma retinol levels and side effects following high-dose retinyl acetate in breast cancer patientsM Resasco, L Canobbio, F Trave, et al.
Cancer Letters|December 1, 1983
Hematoporphyrin derivative photoradiation therapy in murine solid tumorsG Canti, L Ricci, V Cantone, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Anti-Cancer Drugs|February 1, 1996
Terminally L-modified oligonucleotides: pairing, stability and biological propertiesL Tondelli, A Garbesi, S Morelli, et al.
Anti-Cancer Drug Design|January 1, 1996
Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell lineS Morelli, A Alama, A Quattrone, et al.
British Journal of Cancer|August 1, 1988
DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivityO Marelli, P Franco, G Canti, et al.
Anti-Cancer Drugs|April 1, 1993
Oligonucleotide degradation contributes to resistance to antisense compoundsA Ryte, S Morelli, M Mazzei, et al.
Pharmacological Research|September 1, 1990
Diethylstilbestrol (DES) and recombinant human growth hormone (rhGH) as modulators of breast cancer proliferative activityA Alama, F Barbieri, G Gardin, et al.
Neoplasma|January 1, 1987
Photodynamic therapy in vitro and in vivo with hematoporphyrin derivative and laser lightG Canti, L Ricci, A Ferrario, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1997
The antisense bcl-2-IgH transcript is an optimal target for synthetic oligonucleotidesS Morelli, D Delia, S Capaccioli, et al.
Biochimica Et Biophysica Acta|June 28, 1989
Assimilation of LDL by experimental tumours in miceP Lombardi, G Norata, F M Maggi, et al.
Anticancer Research|November 1, 1988
Plasma retinol levels and side effects following high-dose retinyl acetate in breast cancer patientsM Resasco, L Canobbio, F Trave, et al.
Cancer Letters|December 1, 1983
Hematoporphyrin derivative photoradiation therapy in murine solid tumorsG Canti, L Ricci, V Cantone, et al.
Pageof 11